Professional Documents
Culture Documents
JE Sero Tahap Klinis Dr. Shofia
JE Sero Tahap Klinis Dr. Shofia
Alpha-Fetoprotein
Hepatocellular (AFP)
carcinoma (HCC) The main detection,
ranks as the sixth treatment of HCC screening,
most prevalent is surgical surveillance,
malignancies and resection, but therapeutic
the third leading recurrency of the efficacy
cause of cancer- tumor is high measurement, and
related deaths prognostic
evaluation
3
INTRODUCTION
Clinical Characteristic
Postoperative Follow-Up
• 4-6 weeks after surgery
Study endpoints
• Overall survival (OS)
• Recurrence-free survival (RFS)
7
METHODS
The SPSS software version 25.0
• Proportions (%) or
Cate- The OS • Kaplan–Meier method
numbers (n) and compared
gorical and RFS generated by the Log rank
using the χ2 test or Fisher’s
variables rates test.
exact test.
The postoperative mortality and overall recurrence rates for patients in the
IBR group were significantly higher than those in the CBR group (97.8% vs
56.4%, and 80.6% vs 47.1%, respectively, both P < 0.001). The rate of early
HCC recurrence in the IBR group was also significantly higher than those in
the CBR group (92.5% vs 33.3%, P < 0.001), despite the two groups having
comparable rates of late HCC recurrence (62.5% vs 35.3% , P = 0.142).
Multivariate Cox-regression analysis demonstrated that postoperative IBR
was also independently associated with increased early recurrence rate
following curative liver resection for high-AFP HCC (HR, 5.43; 95% CI,
4.08–7.25; P < 0.001).
9
RESULTS
N=549
456 (83.1%) CBR
Postoperative
serum AFP level
93 (16.9%) IBR
10
RESULTS
11
RESULTS
<
Similar results of early HCC recurrence with significant difference (both P<0.001) were
showed in the subgroup cohorts of patients with preoperative intermediately high (Figure
3A) and extremely high (Figure 4A) AFP level
13
DISCUSSION
Published studies on AFP use to predict recurrence and survival after curative liver
resection are very limited.
In the past two decades, accurate In this study, the rate of early
prediction and early detection of recurrence within 2 years after surgery
tumor recurrence can be predicted by among patients with postoperative IBR
detecting circulating tumor cells, cell- was as high as 92.5%, suggesting that
free DNA, or microRNAs. these patients with high risks of early
These techniques suffer from the need recurrence should be given close
for high technology and high costs surveillance to detect early HCC
which limit their generalizability. recurrence and to consider offering
early treatments against recurrence.
15
DISCUSSION
THANK
YOU
18
19
Alpha-Fetoprotein
The mechanism of increasing AFP serum level is not quite clear, but the AFP
levels may be elevated because of production by the tumor or by regenerating
hepatocytes
AFP levels can also be elevated because of other conditions, such as following
liver resection (transient until regeneration complete), recovery following toxic
injury, or seroconversion following hepatitis B infection (typically inducing
transient exacerbation of inflammation
21
Strategies for recurrence
History taking
Physical examination
Detection of serum AFP level
If the AFP serum is not rise Ultrasonography or contrast-enhanced computed tomography
(CT) or magnetic resonance imaging (MRI) of the upper abdomen
Bone scan or positron emission tomography were performed as clinically indicated
The first follow-up evaluation, either during hospitalization or at an outpatient setting, was
performed at 4-6 weeks after surgery. These patients were subsequently followed-up at 2- or 3-
monthly intervals for the first half-year after surgery, 3- to 4-monthly for the next 1.5 years, and
then 3- to 6-monthly thereafter.
22
HBV and HCV Infection
Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are
the most important causes of hepatocellular carcinoma (HCC)
HBV and HCV infection can cause chronic injury to the liver, with
subsequent progression to severe fibrosis and cirrhosis. The presence of
cirrhosis is a major risk factor for the development of HCC.
HBV and HCV may be directly and indirectly involved in
hepatocarcinogenesis.
23
24
Similar to nonviral liver diseases, HBV and HCV infection can cause
chronic injury to the liver, with subsequent progression to severe
fibrosis and cirrhosis. The presence of cirrhosis is a major risk factor
for the development of HCC.
26
Post-treatment biomarker response